Relutrigine
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Apr 11, 2023 (NCT05818553)
Timeline
Indications
Studied for
Mechanism of action
SCN10A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCOC(F)(F)c1nnc2cnc(-c3cnc(OCC(F)(F)F)c(F)c3)cn12- Mol. weight
- 407.27 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314479 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07010471 | Phase 3 | Jul 9, 2025 | Praxis Biologics |
| NCT05818553 | Phase 2 | Apr 11, 2023 | Praxis Biologics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Praxis Biologics | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1